Cargando…
Role of Famotidine and Other Acid Reflux Medications for SARS-CoV-2: A Pilot Study
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus-19 disease (COVID-19) pandemic. The H-2 blocker famotidine has been suggested as an FDA-approved drug that could potentially be repurposed for treatment of COVID-19. Famotidine has since be...
Autores principales: | Balouch, Bailey, Vontela, Swetha, Yeakel, Heather, Alnouri, Ghiath, Sataloff, Robert T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Voice Foundation. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817459/ https://www.ncbi.nlm.nih.gov/pubmed/33516648 http://dx.doi.org/10.1016/j.jvoice.2021.01.007 |
Ejemplares similares
-
Otolaryngology-related Google Search trends during the COVID-19 pandemic
por: Pier, Matthew M., et al.
Publicado: (2020) -
The impact of identifying laryngeal obstruction syndromes on reducing treatment of pediatric asthma: A systematic review
por: Zhang, Caseng, et al.
Publicado: (2022) -
Famotidine Against SARS-CoV2: A Hope or Hype?
por: Ghosh, Ritwik, et al.
Publicado: (2020) -
The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
por: Loffredo, Madeline, et al.
Publicado: (2021) -
Pharmacokinetics and efficacy of intravenous famotidine in adult cattle
por: Balcomb, Christie C., et al.
Publicado: (2018)